JCR Pharmaceuticals Co's quarterly market cap
increased
from Jun. 2023 (円158,341 Mil) to Sep. 2023 (円186,603 Mil) but then
declined
from Sep. 2023 (円186,603 Mil) to Dec. 2023 (円146,267 Mil).
JCR Pharmaceuticals Co's annual market cap
declined
from Mar. 2022 (円279,320 Mil) to Mar. 2023 (円176,308 Mil) and
declined
from Mar. 2023 (円176,308 Mil) to Mar. 2024 (円106,957 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. JCR Pharmaceuticals Co's Enterprise Value for Today is 円75,763 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of JCR Pharmaceuticals Co's Market Cap
For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JCR Pharmaceuticals Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Market Cap distribution charts can be found below:
* The bar in red indicates where JCR Pharmaceuticals Co's Market Cap falls into.
JCR Pharmaceuticals Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
JCR Pharmaceuticals Co's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JCR Pharmaceuticals Co (TSE:4552) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
JCR Pharmaceuticals Co Market Cap Related Terms
Thank you for viewing the detailed overview of JCR Pharmaceuticals Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
JCR Pharmaceuticals Co (TSE:4552) Business Description
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4552 has been successfully added to your 